ELDN: Eledon Pharmaceuticals O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Eledon Pharmaceuticals (ELDN) uchun xavflar standart laboratoriya nazorati va ishlab chiqarish zavodlarining yetishmasligi bilan cheklangan bo'lib, bu aksiya P/E ko'rsatkichi va o'sish baholashlari bilan tasdiqlanadi. Biroq, 0.00 ko'rsatkichi yuqori inqirozga chidamlilik va klinik sinovlarga bog'liqlik fonida ushbu metrikaning holatini aks ettiradi. Transplantologiyadagi noyob molekulalar uchun patent himoyasi monopol narx belgilash imkoniyatini kafolatlab, operatsion tahdidlarni minimallashtiradi.
Eledon Pharmaceuticals (ELDN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Eledon Pharmaceuticals|ELDN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi eledon.com|ELDN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Eledon|ELDN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Eledon Pharmaceuticals|Tezkor likvidlik eledon.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ELDN - Sof foyda|Kutilayotgan sof foyda Eledon Pharmaceuticals|ELDN - P/E multiplikatori|Narxning kelajakdagi foydaga nisbati Eledon Pharmaceuticals, Inc|ELDN - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Eledon|ELDN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Eledon Pharmaceuticals|ELDN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi eledon.com|ELDN - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Eledon Pharmaceuticals
Kompaniyaning umumiy tahlili:ELDN - Eledon Pharmaceuticals Inc.
Aktivlarning investitsiya ishonchliligini baholash bozor qiymatini foyda dinamikasi bilan solishtirishni talab qiladi, bu esa P/E koeffitsiyentini biznesning o'sish sur'atiga bo'lish orqali amalga oshiriladi. PEG koeffitsiyentini tahlil qilish orqali investor Eledon Pharmaceuticals (ELDN) dori vositalarining patent himoyasi va transplantologiyadagi monopoliyasi joriy kapitalizatsiyani qanchalik darajada oqlashini aniqlashi mumkin, bu esa kompaniyaning fundamental salohiyatiga nisbatan past baholanganligini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pharvaris Pharma|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|TRML (tourmalinebio.com) - Narxning foydaga va o‘sish sur’atiga nisbati|PGEN (Precigen) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|PEG multiplikatori NKTR|Upstream Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|immunome.com (IMNM) - O‘sish sur’atiga tuzatilgan narx-foyda|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|KALV (KalVista Pharma) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|rigel.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ANAB|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENGN (enGene Bio)|PEG multiplikatori rapt.com RAPT|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|PEG multiplikatori Ventyx Biosciences, Inc|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|PEG multiplikatori AGEN (Agenus Inc.)|Climb Bio Inc. (CLYM) - O‘sish sur’atiga tuzatilgan narx-foyda|ZURA: Narx-foyda va o‘sish multiplikatori|ATYR - PEG multiplikatori|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|IMA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|STTK (Shattuck Labs Inc) - PEG multiplikatori|Equillium Bio (EQ) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori CNTB|Narx-foyda va o‘sish multiplikatori immunic-therapeutics.com IMUX|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|ACET: Narxning foydaga va o‘sish sur’atiga nisbati|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|INMB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda kezarlifesciences.com KZR|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Narxning foydaga va o‘sish sur’atiga nisbati AKTX (Akari Therapeutics PLC)|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|QTTB: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|EDSA (edesabiotech.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati CARM (Carisma Therapeutics Inc.)|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND: PEG multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INDP|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati affimed.com|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
